NCT02386501 — HER2 Expressing Solid Tumors trial site landscape

Public-registry site landscape for NCT02386501, a HER2 Expressing Solid Tumors study sponsored by Advaxis, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT02386501 (registry record)
Sponsor	Advaxis, Inc.
Condition(s)	HER2 Expressing Solid Tumors
Phase	PHASE1 / PHASE2
Listed sites	6
Site countries	United States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT02386501 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.